Search Results - "Stade, Barbara"
-
1
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy
Published in Medicine (Baltimore) (01-11-2016)“…Currently interferon alfa-2b (IFNα-2b) is an approved adjuvant drug for high-risk melanoma patients that leads to an improvement in disease-free survival…”
Get full text
Journal Article -
2
The GERMELATOX DeCOG-trial: Attitude of German melanoma patients towards toxicity during adjuvant interferon treatment—Differences between the patient's and the physician's perspective
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
3
The GERMELATOX DeCOG-trial: German melanoma patients and their attitude toward toxicity during adjuvant interferon treatment
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
4
-
5
Sa1053 Age-Dependent Rise in Early Hemoglobin (HB) Decline Contributes to a Higher Frequency of Anemia in Elder Patients Treated With Peginterferon Alfa-2B (Peg2b)/Ribavirin (RBV) for Chronic HCV Genotype 1 (G1) Infection
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2012)Get full text
Journal Article -
6
12-O-Tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha -mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecule-1 promoter
Published in The Journal of biological chemistry (25-02-1994)“…Transcription regulation of the human intercellular adhesion molecule-1 gene by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), tumor necrosis…”
Get full text
Journal Article -
7
Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study
Published in Blood (16-11-2004)“…In high risk Essential Thrombocythemia (ET) there is a indication for cytoreductive therapy. However, especially in younger patients long-term use of…”
Get full text
Journal Article -
8
De novo Expression of Intercellular-Adhesion Molecule 1 in Melanoma Correlates with Increased Risk of Metastasis
Published in Proceedings of the National Academy of Sciences - PNAS (1989)“…The 89-kDa cell surface glycoprotein, P3.58, is detectable on advanced human melanomas in situ but not on benign melanocytes or early melanomas. cDNA cloning…”
Get full text
Journal Article -
9
Structural characteristics of the 5' region of the human ICAM-1 gene
Published in Immunobiology (1979) (01-12-1990)“…The ICAM-1 glycoprotein, one of the major cellular adhesion molecules, exhibits a diverse and highly regulated tissue distribution. To better understand the…”
Get more information
Journal Article -
10
Autotransplantation of B-cell purged peripheral blood progenitor cells in B-cell lymphoma
Published in The Lancet (British edition) (25-03-1995)Get more information
Journal Article -
11
The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule, ICAM-1
Published in Immunobiology (1979) (01-12-1988)“…The 89kd cell surface glycoprotein, P3.58, is expressed on human malignant melanomas in situ where it is associated with an increased risk of metastatic…”
Get more information
Journal Article